BCA
Benchmark Capital Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $3.66M | Sell |
83,925
-5,200
| -6% | -$227K | 3.64% | 4 |
|
|
2018
Q3 | $3.93M | Sell |
89,125
-1,600
| -2% | -$70.5K | 2.95% | 6 |
|
|
2018
Q2 | $3.29M | Sell |
90,725
-6,800
| -7% | -$247K | 2.49% | 7 |
|
|
2018
Q1 | $3.46M | Sell |
97,525
-2,550
| -3% | -$90.5K | 2.74% | 7 |
|
|
2017
Q4 | $3.63M | Sell |
100,075
-10,600
| -10% | -$384K | 2.83% | 5 |
|
|
2017
Q3 | $3.95M | Sell |
110,675
-6,299
| -5% | -$225K | 3.07% | 4 |
|
|
2017
Q2 | $3.93M | Buy |
116,974
+25
| +0% | +$840 | 3.1% | 4 |
|
|
2017
Q1 | $4M | Sell |
116,949
-2,400
| -2% | -$82.1K | 3.16% | 4 |
|
|
2016
Q4 | $3.88M | Sell |
119,349
-300
| -0.3% | -$9.74K | 3.21% | 4 |
|
|
2016
Q3 | $4.05M | Sell |
119,649
-1,000
| -0.8% | -$33.9K | 3.06% | 4 |
|
|
2016
Q2 | $4.25M | Buy |
120,649
+6,300
| +6% | +$222K | 3.46% | 4 |
|
|
2016
Q1 | $3.39M | Buy |
114,349
+16,500
| +17% | +$489K | 2.97% | 3 |
|
|
2015
Q4 | $3.16M | Buy |
97,849
+2,800
| +3% | +$90.4K | 2.67% | 8 |
|
|
2015
Q3 | $2.99M | Hold |
95,049
| – | – | 2.43% | 8 |
|
|
2015
Q2 | $3.19M | Sell |
95,049
-700
| -0.7% | -$23.5K | 2.24% | 9 |
|
|
2015
Q1 | $3.33M | Buy |
95,749
+21,598
| +29% | +$751K | 2.19% | 10 |
|
|
2014
Q4 | $2.31M | Sell |
74,151
-200
| -0.3% | -$6.23K | 1.55% | 20 |
|
|
2014
Q3 | $2.2M | Sell |
74,351
-38,149
| -34% | -$1.13M | 1.52% | 19 |
|
|
2014
Q2 | $3.34M | Buy |
112,500
+300
| +0.3% | +$8.9K | 2.09% | 11 |
|
|
2014
Q1 | $3.6M | Sell |
112,200
-300
| -0.3% | -$9.64K | 2.5% | 6 |
|
|
2013
Q4 | $3.45M | Sell |
112,500
-7,850
| -7% | -$240K | 2.39% | 7 |
|
|
2013
Q3 | $3.46M | Sell |
120,350
-13,950
| -10% | -$401K | 2.48% | 7 |
|
|
2013
Q2 | $3.76M | Buy |
+134,300
| New | +$3.76M | 2.9% | 3 |
|